AstraZeneca has struck a $1bn (£773m) deal to buy a Belgian biotech company that specialises in cancer immunotherapies, the latest in a string of acquisitions that also yielded positive results for a late-stage rare disease drug on Monday.
EsoBiotec, a small privately held firm, develops in-vivo CAR-T cell therapies that empower the immune system to attack cancers, and could offer many more patients access to cell therapy treatments, provided in minutes rather than weeks.
The deal marks the latest acquisition by AstraZeneca, which is Britain’s biggest listed company valued at £184bn, as the pharmaceutical group continues to expand its global operations. Its share price fell by 1.2% on Monday afternoon.
Read Full Article Here
AstraZeneca pays up to $1bn for biotech firm ‘that could transform cell therapy’
- by: Julia Kollewe
- 03.17.25
- Source:
The Guardian
- 03/17/2025
Follow us
Read our latest news on any of these social networks!
Get latest news delivered daily!
We will send you breaking news right to your inbox
Have a tip? Let us know!
Recent Articles
- by: Kevin Breuninger
- Source:
CNBC
- 06/05/2025
Musk whips opposition to Trump tax plan: ‘KILL the BILL’
Elon Musk ramped up his attacks against the massive tax-cut bill President Donald Trump is pushing Congress to pass.
- by: Joshua Wilburn
- Source:
ok magazine
- 06/05/2025
Donald Trump Declares Joe Biden's Autopen Usage the 'Biggest Political Scandal' in American History
When most Americans were sleeping, President Donald Trump took to Truth Social to unleash a fiery tirade against his political predecessor.
- by: Emma Tucker
- Source:
CNN
- 06/05/2025
US Education Department threatens Columbia University’s accreditation over campus antisemitism concerns
The Trump administration has escalated its fight with Columbia University, declaring the school doesn’t meet accreditation standards because of its failure to protect Jewish students.
- by: Gabe Cohen
- Source:
CNN
- 06/04/2025
FEMA head told staff he was previously unaware US has a hurricane season
Staff at the Federal Emergency Management Agency were caught off-guard and left bewildered when the disaster relief agency’s new acting head David Richardson told personnel that he was previously unaware the United States has a hurricane season, which started Sunday.